涪陵榨菜（002507.SZ） 2025Q4 收入微增，销售费用加大致盈利短期承压 2026 年 03 月 02 日 投资评级：买入（维持） | 日期 | 2026/2/27 | 证书编号：S0790520030003 | | --- | --- | --- | | 当前股价(元) | 13.30 | | | 一年最高最低(元) | 14.43/12.23 | | | 总市值(亿元) | 153.47 | | | 流通市值(亿元) | 152.81 | | | 总股本(亿股) | 11.54 | | | 流通股本(亿股) | 11.49 | | | 近 3 个月换手率(%) | 74.68 | | 股价走势图 数据来源：聚源 -16% -8% 0% 8% 16% 24% 32% 2025-03 2025-07 2025-11 涪陵榨菜 沪深300 食品饮料/调味发酵品Ⅱ 春节错期致春节备货延后，2025Q4 收入仅平稳微增 考虑到 2026 年春节较晚，从春节备货节奏来看，部分春节备货延迟至 2026Q1， 致公司 2025Q4 营收在 2024Q4 低基数背景下仅微增 1.9%。公司在 2025 年积极 进 ...

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [5]. Core Insights - Baoli Foods has established itself as a leader in the Western compound seasoning industry, evolving from single product offerings to comprehensive solutions over its 20-year history [15][16]. - The company has shown steady revenue and profit growth, with a projected CAGR of 14.09% from 2022 to 2024, and a net profit of 1.92 billion yuan in Q1-Q3 2025, reflecting a year-on-year increase of 10.59% [1][15]. - The compound seasoning market is expected to grow from 99.7 billion yuan in 2020 to 126.5 billion yuan by 2024, with a CAGR of 6.1% [2]. Company Overview - Baoli Foods operates three main business segments: compound seasonings, light cooking solutions, and beverage dessert ingredients, serving both B-end and C-end markets [15]. - The company has a stable management team with extensive industry experience, which supports strategic execution and innovation [26][29]. - The financial performance indicates a robust growth trajectory, with revenue expected to reach 2.998 billion yuan in 2025, reflecting a year-on-year growth rate of 13.1% [10]. Industry Analysis - The compound seasoning market is characterized by strong demand from both enterprise and individual customers, with enterprise customer revenue projected to grow from 58.8 billion yuan to 73.1 billion yuan from 2020 to 2024, and individual customer revenue expected to increase from 40.9 billion yuan to 53.4 billion yuan [2]. - The restaurant service market in China is projected to reach 5.6 trillion yuan by 2024, with a CAGR of 8.78% from 2020 to 2024, driven by the growth of chain restaurants and the takeout market [3]. - The C-end market for pre-prepared meals is expected to grow significantly, with the market size projected to increase from 171.2 billion yuan in 2019 to 485 billion yuan by 2024, achieving a CAGR of 23.15% [4].

Investment Rating - The report assigns an "Outperform" rating to the company, marking the first coverage of the stock [5]. Core Insights - The company is a leader in the Chinese yeast industry and the second-largest yeast producer globally, with a focus on yeast and deep-processing products. It has a total fermentation capacity of 400,000 tons and expects to achieve a revenue of 15.197 billion yuan and a net profit of 1.325 billion yuan in 2024 [1][3]. - The yeast industry is characterized by an oligopolistic market structure, with the top three companies holding over 70% of the market share globally. The company holds a 55% market share in China, leading the domestic market [1][42]. - The company has established a global production and R&D system, enhancing its competitive barriers. It has invested in local production facilities to stabilize supply and mitigate raw material price fluctuations [2][3]. Summary by Sections Company Overview - The company has been deeply involved in the yeast industry for 40 years, evolving from a local state-owned enterprise to a global giant. It produces a wide range of products, including bread yeast, yeast extract, and nutritional health products, with sales channels spanning over 160 countries [13][15]. Market Position and Financial Performance - The company has a strong financial outlook, with projected revenues of 16.723 billion yuan in 2025, reflecting a 10% year-on-year growth. The net profit is expected to reach 1.585 billion yuan, a 19.6% increase [3][4]. - The company’s gross margin is projected to improve due to declining raw material costs, particularly sugar molasses, which accounts for approximately 40% of total costs [2][27]. Growth Drivers - The company’s growth is supported by two main engines: the expansion of its overseas business, which is expected to increase its revenue share from 28% in 2020 to 38% in 2024, and the rising demand for yeast extract as a natural flavoring agent [2][3]. - The company maintains a robust R&D investment, with a research expense ratio consistently above 4%, which has led to a strong patent portfolio and enhanced bargaining power with downstream customers [2][3]. Industry Characteristics - The yeast industry is capital-intensive, with high barriers to entry due to the significant investment required for production facilities. The company’s capital expenditure per unit capacity is 10-18 times that of the seasoning industry [1][48]. - The price of sugar molasses, a key raw material, is closely linked to white sugar prices and exhibits cyclical fluctuations. The company anticipates a downward trend in sugar molasses prices by 2025, which will support profit recovery [1][56]. Valuation - The report estimates a reasonable valuation range for the company’s stock between 49.98 and 56.79 yuan, indicating a potential premium of 10%-25% compared to the current stock price of 45.33 yuan [5][3].

Investment Rating - The report assigns an "Outperform" rating to the company, marking its first coverage [5]. Core Insights - The company is a leader in the Chinese yeast market and the second-largest yeast producer globally, with a total fermentation capacity of 400,000 tons and sales of 415,400 tons of yeast and deep-processed products expected in 2024 [1][3]. - The company has a comprehensive global layout with 11 production bases in China and overseas factories in Egypt and Russia, distributing products to over 160 countries and regions [1]. - The yeast industry is characterized by an oligopolistic structure, with the top three companies holding over 70% market share globally, and the company holds a 55% market share in China [1][42]. - The company has a strong competitive edge due to its global capacity and R&D system, with a consistent R&D expense ratio of over 4% and numerous domestic and international patents [2][3]. - The company is expected to benefit from a decline in raw material costs, particularly molasses, which is projected to support profit recovery as sugarcane planting areas expand in China [1][2]. Financial Projections - The company is forecasted to achieve total revenue of CNY 167.2 billion, CNY 188.4 billion, and CNY 210.0 billion for the years 2025 to 2027, representing year-on-year growth rates of 10.0%, 12.6%, and 11.5% respectively [3][4]. - The projected net profit for the same period is CNY 15.8 billion, CNY 19.7 billion, and CNY 23.1 billion, with year-on-year growth rates of 19.6%, 24.5%, and 17.3% respectively [3][4]. - The earnings per share (EPS) are expected to be CNY 1.82, CNY 2.27, and CNY 2.66 for 2025 to 2027 [3][4]. - The current stock price corresponds to a price-to-earnings (PE) ratio of 24.8, 19.9, and 17.0 for the years 2025 to 2027, indicating a potential premium of 10%-25% compared to the estimated valuation range of CNY 49.98 to CNY 56.79 [3][4].

Group 1 - Yongtai Technology's wholly-owned subsidiary has received approval for trial production of a lithium battery additive project with an annual capacity of 5,000 tons, set to begin trial production [1] - Mengke Pharmaceutical has decided to terminate its plan to issue shares to a specific entity due to ongoing disagreements among major shareholders, which could impact the company's stable operations [1] - Anhui Construction's subsidiary has been approved to register and issue debt financing tools totaling 15 billion yuan, including 5 billion yuan in short-term financing notes and 10 billion yuan in medium-term notes [2] Group 2 - Koli'er plans to repurchase shares worth between 10 million and 20 million yuan, with a maximum repurchase price of 20.94 yuan per share, to implement an employee stock ownership plan [2] - Xinhua Pharmaceutical has received approval for the production of fumaric acid volnoral raw materials, which are used to treat gastroesophageal reflux disease [3] - Lianhuan Pharmaceutical has received approval for additional specifications of tadalafil tablets, expanding its product offerings for treating erectile dysfunction and benign prostatic hyperplasia [5] Group 3 - Greenland Holdings reported an increase of 1,834 lawsuits with a total amount of 6.587 billion yuan from October 21 to November 13, 2025 [7] - Lianke Technology plans to invest up to 600 million yuan of idle funds in low-risk financial products [8] - Yinglian Co. signed a strategic procurement contract for 5,000 million square meters of composite aluminum foil with a leading new energy technology company [10] Group 4 - China Eastern Airlines reported a 10.58% year-on-year increase in passenger turnover for October, with a capacity increase of 6.84% [12] - China National Airlines reported an 8.7% year-on-year increase in passenger turnover for October, with domestic and international capacity also showing growth [15] - Oupai Home plans to use 320 million yuan of idle funds to purchase structured deposits with expected annual yields between 0.65% and 2.50% [16] Group 5 - Tianwei Food has submitted H-share issuance application materials to the Hong Kong Stock Exchange, which have been accepted by the China Securities Regulatory Commission [18] - Guizhou Aviation plans to establish a subsidiary focused on the research, production, and market expansion of intelligent automotive components, with initial operating funds of 40 million yuan [20] - Daimai Co. plans to invest 100 million yuan to establish a wholly-owned subsidiary in Shanghai focused on robotics technology [22] Group 6 - Founder Securities has received approval to issue company bonds totaling up to 30 billion yuan [24] - Hengrui Medicine has received clinical trial approvals for multiple drugs, indicating ongoing research and development efforts [26] - Zhaojing Pharmaceutical's product ZG006 has received orphan drug designation from the FDA, providing various benefits for its development in the U.S. market [39]

Investment Rating - The investment rating for the company is "Outperform the Market" [5][3][15] Core Views - The company achieved a total revenue of 2.411 billion yuan in the first three quarters of 2025, representing a year-on-year growth of 1.98%. The net profit attributable to shareholders decreased by 9.30% to 392 million yuan [8][3] - The company continues to drive growth through external acquisitions, with a notable acquisition of 55% of Shandong Yipin Weixiang Food Technology Co., Ltd. in September 2025, which allows entry into the compound seasoning sauce market [11][13] - The company’s gross margin improved to 40.5% in Q3 2025, up 1.6 percentage points year-on-year, attributed to product mix optimization and raw material cost benefits [2][10] Summary by Sections Financial Performance - In Q3 2025, the company reported total revenue of 1.020 billion yuan, a year-on-year increase of 13.79%. The net profit attributable to shareholders was 202 million yuan, up 8.93% year-on-year [8][10] - The revenue from offline and online channels in Q3 2025 was 790 million yuan and 220 million yuan, respectively, showing a year-on-year growth of 4.5% and 60.7% [10][2] Profitability and Cost Management - The company’s selling and administrative expense ratios were 10.9% and 3.8%, respectively, with selling expenses stabilizing compared to Q2 [2][10] - The net profit margin for Q3 2025 was 19.1%, down 0.9 percentage points year-on-year [2][10] Future Outlook - The revenue forecasts for 2025-2027 have been adjusted to 3.561 billion yuan, 3.858 billion yuan, and 4.156 billion yuan, respectively, with expected year-on-year growth rates of 2.4%, 8.4%, and 7.7% [3][14] - The net profit forecasts for the same period are 600 million yuan, 690 million yuan, and 750 million yuan, with expected declines of 3.5% and 15.0% in 2025 and 2026, respectively [3][14]

Investment Rating - The investment rating for Tianwei Foods is maintained at "Outperform" [1] Core Views - The company's Q3 2025 revenue and net profit slightly exceeded expectations, with revenue of 2.41 billion and net profit of 390 million, reflecting a year-on-year change of +2.0% and -9.3% respectively. Q3 alone saw revenue of 1.02 billion and net profit of 200 million, with year-on-year changes of +13.8% and +8.9% respectively [1][2] - The forecast for net profit from 2025 to 2027 is adjusted to 610 million, 680 million, and 750 million respectively, with corresponding PE ratios of 21.0, 18.7, and 17.0 times [1] Revenue and Profit Analysis - Q3 2025 revenue growth was driven by various product categories, with base sauces, recipe-style seasonings, and others growing by +25.0%, +14.9%, and +121.1% year-on-year respectively. However, sausage and cured meat seasonings saw a decline of 22.2% due to seasonal sales patterns [2] - Online channel revenue grew significantly by 60.6% year-on-year, while offline channels saw a modest increase of 4.5% [2] - Regional performance showed declines in the western and central regions, while eastern, southern, and northern regions experienced revenue growth of 45.6%, 20.9%, and 13.0% respectively [2] Margin and Expense Insights - Gross margin improved by 1.6 percentage points to 40.5%, while net margin decreased by 0.5 percentage points to 20.7% year-on-year. On a quarter-on-quarter basis, gross margin increased by 3.5 percentage points [3] - Overall expense ratio increased by 1.4 percentage points year-on-year, primarily due to a rise in sales expense ratio, which increased by 3.1 percentage points to 10.9% [3] Strategic Outlook - The company is expected to solidify its position in the C-end channel while focusing on the small B channel. The completion of acquisitions such as Shicui and Jiadian Zhiwei is anticipated to enhance channel capabilities, supporting rapid revenue growth during peak seasons [4] - There is an expectation for the company to reduce expenses in traditional supermarket channels while increasing investment in small B channels, aiming for gradual volume growth in these areas [4]

Investment Rating - The investment rating for the company is "Outperform the Market" [5][14][16] Core Views - The company achieved a revenue of 2.133 billion yuan in the first three quarters of 2025, representing a year-on-year growth of 10.50%. The net profit attributable to shareholders was 192 million yuan, also up by 10.59% year-on-year [8][11] - The company is focusing on a dual-driven strategy (BC), extending from restaurant supply to a food supply chain platform, benefiting from the trend of restaurant chain standardization [2][13] Financial Performance Summary - For Q3 2025, the company reported a revenue of 753 million yuan, a year-on-year increase of 14.60%, and a net profit of 75 million yuan, up 15.71% year-on-year [8][11] - The gross margin for Q3 2025 was 32.55%, an increase of 1.27 percentage points year-on-year, primarily due to the higher proportion of the more profitable light cooking business [2][11] - The company expects revenue for 2025-2027 to be 2.904 billion, 3.249 billion, and 3.579 billion yuan, with year-on-year growth rates of 9.5%, 11.9%, and 10.1% respectively [3][14] Product and Market Dynamics - The revenue growth in Q3 2025 was driven by strong performance in compound seasoning and light cooking solutions, with respective year-on-year increases of 9.7% and 25.0% [11][2] - Direct sales channels showed a robust growth of 17.7% year-on-year, indicating a positive trend in customer demand [11][2] Earnings Forecast and Valuation - The forecasted earnings per share (EPS) for 2025-2027 are 0.64, 0.74, and 0.82 yuan, with corresponding price-to-earnings (PE) ratios of 22.5, 19.4, and 17.5 [3][14] - The company maintains a strong return on equity (ROE) forecast of 18.3% for 2025, increasing to 22.5% by 2027 [4][17]

Investment Rating - The report maintains a "Buy" rating for the company [6] Core Insights - The company focuses on its core vinegar business, achieving steady profit growth with a revenue of 1.628 billion yuan for Q1-Q3 2025, up 6.3% year-on-year, and a net profit attributable to shareholders of 142 million yuan, up 17.98% year-on-year [1] - The online sales channel shows impressive growth, with online revenue increasing by 17.4% year-on-year, while offline sales decreased by 7.1% [2] - The gross margin slightly decreased to 34.71%, down 0.90 percentage points year-on-year, primarily due to changes in product mix [3] - The company aims to strengthen its main business and enhance profitability through quality improvement, innovation, and cost reduction [3] Financial Performance - For Q3 2025, the company reported revenues of 502 million yuan, a decrease of 4.63% year-on-year, and a net profit of 31 million yuan, an increase of 17.65% year-on-year [1] - The company’s revenue from vinegar, wine, sauces, and other products for Q3 2025 was 314 million, 87 million, 59 million, and 39 million yuan respectively, with vinegar showing a growth of 7.3% [2] - The company’s net profit forecast for 2025-2027 is expected to grow by 30.4%, 29.0%, and 18.5% respectively, reaching 166 million, 214 million, and 254 million yuan [3]

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company's gross profit margin significantly improved in Q3, and short-term expense fluctuations do not alter the upward profit trend [5] - The company is expected to maintain rapid growth in overseas revenue, with projected net profits for 2025-2027 at 1.595 billion, 1.993 billion, and 2.315 billion RMB, respectively, reflecting year-on-year growth rates of 20%, 25%, and 16% [5] Financial Performance Summary - For the first three quarters of 2025, the company achieved operating revenue of 11.79 billion RMB, a year-on-year increase of 8%, and a net profit attributable to shareholders of 1.12 billion RMB, up 17.1% year-on-year [7] - In Q3 alone, the company reported revenue of 3.89 billion RMB, a 4% increase year-on-year, and a net profit of 320 million RMB, up 21% year-on-year [7] - The overall gross profit margin for the first three quarters was 25.54%, an increase of 2.26 percentage points compared to the same period last year [7] - The company’s revenue projections for 2025-2027 are 16.741 billion, 19.092 billion, and 21.263 billion RMB, with corresponding year-on-year growth rates of 10.16%, 14.04%, and 11.37% [6][8] Profitability Metrics - The projected earnings per share (EPS) for 2025 is 1.84 RMB, with a price-to-earnings (P/E) ratio of 21.15 [6] - The return on equity (ROE) is expected to improve from 12.23% in 2024 to 15.57% in 2027 [6][8] - The company’s net profit margin is projected to increase from 8.90% in 2024 to 11.40% in 2027 [9]